The trajectory of companies tied to iconic drugs like Viagra presents a nuanced investment picture. While the initial rise of copyright, fueled by Viagra's remarkable popularity, generated substantial wealth , the loss of exclusivity in key markets has introduced substantial uncertainty . Investors are now assessing the impact of lower-cost alterna